RCT Study of Levosimendan Improving Prognosis of Cardiac Arrest
Phase 4
Not yet recruiting
- Conditions
- Heart Arrest
- Interventions
- Drug: physiological salineDrug: Levosimendan Injection
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05956431
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
Not Applicable
Recruiting
- Conditions
- Type2diabetesPregnancy OutcomePregnancy RelatedContinuous Glucose MonitoringTime in Range
- Interventions
- Device: Real-time Continuous Glucose Monitoring System
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2023-07-17
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT05947916
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Robot Assisted Total Hip Arthroplasties
Not Applicable
Completed
- Conditions
- Hip Arthropathy
- Interventions
- Device: "VTS" surgical robotic system
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 138
- Registration Number
- NCT05947734
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Effects of Preoperative Rehabilitation on Tendon Healing and Bone Mineral Density After ACLR
Not Applicable
Not yet recruiting
- Conditions
- Anterior Cruciate Ligament Rupture
- Interventions
- Behavioral: routine treatmentBehavioral: exercise rehablitation
- First Posted Date
- 2023-06-29
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05924178
Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients
Phase 2
Recruiting
- Conditions
- Periodontitis
- Interventions
- Drug: Human Dental Fulp Stem Cells
- First Posted Date
- 2023-06-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 204
- Registration Number
- NCT05924373
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijng, China
Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein
Recruiting
- Conditions
- Antidiabetic DrugsType 2 Diabetes
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT05922852
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing 100191, Beijing, Beijing, China
🇨🇳Peking University Third Hospital, Beijing, Beijing, China
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
Phase 4
Recruiting
- Conditions
- Sporadic and Familial Amyotrophic Lateral Sclerosis
- Interventions
- Drug: PlaceboDrug: FB1006
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT05923905
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors
Phase 1
Not yet recruiting
- Conditions
- SafetyAdvanced Solid TumorStereotactic Body RadiotherapyImmune Checkpoint InhibitorEfficacy
- Interventions
- Drug: CadonilimabRadiation: Stereotactic body radiotherapy
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2023-06-23
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05915481
- Locations
- 🇨🇳
Department of radiation oncology, Peking University Third Hospital, Peking, Beijing, China
Effect of ECPP on Recurrent Bile Duct Stones
Not Applicable
Recruiting
- Conditions
- Sphincterotomy, Endoscopic
- Interventions
- Procedure: ESTProcedure: ECPP
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 108
- Registration Number
- NCT05896280
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults
Recruiting
- Conditions
- Aging
- Interventions
- Drug: Clinical probes
- First Posted Date
- 2023-06-08
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 624
- Registration Number
- NCT05893849
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath